VALLOUREC
Invitation: Vallourec Q2 2025 Results Release and Conference Call - Friday, July 25th, 2025
Invitation: Vallourec Q2 2025 Results Release and Conference Call - Friday, July 25th, 2025
Invitation
Q2 2025 Results Release and Conference Call
Friday, July 25th, 2025
Vallourec will publish Second Quarter and First Half 2025 Results on July 25th, 2025 at 07:30 AM CET.
Philippe Guillemot, Chairman of the Board and Chief Executive Officer, and Sascha Bibert, Chief Financial Officer are pleased to invite you to a presentation of the results via conference call and audiocast at 09:30 AM CET.
To connect to the audiocast (live and replay), please visit:
https://channel.royalcast.com/landingpage/vallourec-en/20250725_1/
To participate in the call, please dial:
- UK (Standard International Access): +44 (0) 33 0551 0200
- US: +1 786 697 3501
- FR: +33 (0) 1 70 37 71 66
Password: Vallourec
The presentation will be available from 09:00 AM CET on Vallourec’s website: https://www.vallourec.com/en/investors
About Vallourec
Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec’s pioneering spirit and cutting-edge R&D open new technological frontiers. With close to 13,000 dedicated and passionate employees in more than 20 countries, Vallourec works hand-in-hand with its customers to offer more than just tubes: Vallourec delivers innovative, safe, competitive and smart tubular solutions, to make every project possible.
Listed on Euronext in Paris (ISIN code: FR0013506730, Ticker VK), Vallourec is part of the CAC Mid 60, SBF 120 and Next 150 indices and is eligible for Deferred Settlement Service.
In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R4074, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CGTN31.8.2025 12:50:06 CEST | Press release
CGTN: President Xi highlights friendship, cooperation and multilateralism at SCO Summit
Novo Nordisk A/S31.8.2025 09:09:18 CEST | Press release
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Novartis Pharma AG30.8.2025 17:00:00 CEST | Press release
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
F. Hoffmann-La Roche Ltd30.8.2025 16:30:00 CEST | Press release
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
CGTN30.8.2025 11:44:44 CEST | Pressemeddelelse
CGTN: Arven efter Flying Tigers fejres for at styrke det varige bånd mellem Kina og USA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom